Benralizumab Proves Effective for Eosinophilic Granulomatosis With Polyangiitis

(MedPage Today) -- At the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, researchers reported that treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news